Search

everythinglearnresearchcommunity

for

Search:↓

Older obese women with PCOS have higher cardiovascular and metabolic risks despite lower androgen levels.

Prostate-specific antigen may be a new marker for excess male hormones in women with polycystic ovary syndrome.

COVID-19 and hypopituitarism (reduced pituitary gland function) are linked, with the latter's related health issues potentially worsening COVID-19 outcomes, and COVID-19 possibly increasing risk for pituitary complications.

Insulin resistance is common in PCOS patients and linked to obesity and increased cardiovascular risk.

The conclusion is that while oral contraceptive pills are effective for PCOS-related high androgen levels, new treatments with fewer side effects are needed.

Obese Hispanic women with PCOS are at higher risk for metabolic problems than non-Hispanic white women.

The conclusion is that there's no significant link between male pattern baldness and the severity of coronary artery disease.

The conclusion is that managing cholesterol is important for women, especially during pregnancy, breastfeeding, and with PCOS, and involves regular screening and careful treatment choices.

Using rodents for research shows that health problems in the womb can cause diseases later in life.

AGA risk factors include age, smoking, hypertension for men, and age, dyslipidemia for women; lifestyle changes may help prevention.

Certain gene variations might help protect against insulin resistance and glucose intolerance in people with Polycystic Ovary Syndrome.

Finasteride-treated male rats' offspring had altered glucose metabolism, potentially increasing diabetes risk.

Testosterone replacement therapy improved blood sugar and fat levels without raising prostate cancer risk in Japanese men with low testosterone.

Vitisin A reduces triglycerides better than Cyanidin-3-O-glucoside.

Young Indian women with PCOS have a higher risk of heart disease, not linked to thyroid function but to higher levels of certain fats and homocysteine.

Some women with PCOS have rare genetic variants linked to the condition.

Diet may influence acne development.

The type of PCOS a woman has doesn't strongly predict her skin or metabolic symptoms; obesity is a more important factor.

Acne is a common skin condition linked to diet, hormones, and genetics, and early treatment can prevent scarring.

Polycystic Ovary Syndrome (PCOS) is a hormonal disorder in women that can cause infertility and other health issues, and it may be improved by treatments that increase insulin sensitivity.

N-acetylcysteine was more effective and had fewer side effects than metformin for improving insulin resistance in women with PCOS.

Many women with PCOS have hair loss, linked to age, hirsutism, sleep issues, and smoking.

Androgenetic alopecia is linked to a higher risk of metabolic syndrome.

Blocking glucocorticoid receptors improves glucose metabolism in a PCOS mouse model.

A Western diet may increase acne risk, while a Mediterranean diet and certain supplements can help reduce it.

People with plantar corns and calluses may have a higher chance of having metabolic syndrome.

Acne vulgaris is a common skin condition that can cause low self-esteem and depression, and early treatment is important to prevent scarring.

Chrousos Syndrome is caused by mutations that make the body less sensitive to glucocorticoids, leading to various symptoms and requiring high-dose treatment.

Male pattern baldness, especially the vertex type, could be an early sign of cardiovascular risk factors like high cholesterol and diabetes.

Hair loss may increase heart disease risk.